Marrone Bio Innovations Inc. (MBII)

1.94
NASDAQ : Process Industries
Prev Close 1.92
Day Low/High 1.87 / 1.98
52 Wk Low/High 0.85 / 3.39
Avg Volume 448.90K
Exchange NASDAQ
Shares Outstanding 110.47M
Market Cap 212.10M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We exited one name and added to another during a wild week for stocks.

Keep an Eye on This Portfolio Name

Monday could be exciting for the portfolio as Marrone Bio Innovations is set for a presentation and Q&A.

Stocks Under $10 Weekly Summary

The portfolio had several market outperformers last week and we took some profits in one high-flying position.

Marrone Bio Innovations, Inc. Reports Record Full Year 2017 Financial Results

Marrone Bio Innovations, Inc. Reports Record Full Year 2017 Financial Results

2017 GAAP Revenues Increase 29.4% to Record $18.2 Million; Gross Margins Increase Significantly to 42%

Trimming a Winner Ahead of Earnings

We are reducing our position in Marrone Bio Innovations.

Stocks Under $10 Weekly Summary

We added 2 Bullpen names during a challenging week for the market.

Stocks Under $10 Weekly Summary

During a ‘noisy’ week for the portfolio, we added a small speculative position in a payment-processing name.

Marrone Bio Innovations Announces Zequanox® Distribution Partnership

Marrone Bio Innovations Announces Zequanox® Distribution Partnership

Leading Global Producer of Specialty Chemicals for Water Intensive Industries, Solenis, to Distribute Zebra and Quagga Molluscicide in North America

Stocks Under $10 Weekly Summary

The strength exhibited by the Russell 2000 paved the way for portfolio last week.

Stocks Under $10 Weekly Summary

We threw in the towel last week on 2 positions and initiated a small stake in an ancillary cannabis play.

Stocks Under $10 Weekly Summary

During a shortened trading week we closed out of one position and added to another after earnings reports.

Marrone Bio Innovations And Groundwork BioAg Bio-stacked Microbial Seed Treatments Result In Increased Corn And Soybean Yields For The Second Field Trial Season

Marrone Bio Innovations And Groundwork BioAg Bio-stacked Microbial Seed Treatments Result In Increased Corn And Soybean Yields For The Second Field Trial Season

Companies to Focus on Targeted Market Entry for Organic Seed Companies and Growers

Stocks Under $10 Weekly Summary

We shed two positions last week as the market roared back.

Stocks Under $10 Weekly Summary

We added to several positions on weakness during a challenging last week for the stock market.

Marrone Bio Innovations, Inc. Announces Closing Of Private Placement And Debt Refinancing Transactions

Marrone Bio Innovations, Inc. Announces Closing Of Private Placement And Debt Refinancing Transactions

Proceeds Provide Resources to Execute Upon Business Strategy

Stocks Under $10 Weekly Summary

We exited one position and added to another as volatility returned to the stock market last week.

Haven® Sun Protectant Approved In California

Haven® Sun Protectant Approved In California

Multi-Year Trials with Haven Show Significant Increases in Almond and Walnut Yields

Stocks Under $10 Weekly Summary

It was a mixed week for the portfolio as we trimmed one position and added to the Bullpen.

Marrone Bio Innovations Announces Distribution Partnership In The Philippines

Marrone Bio Innovations Announces Distribution Partnership In The Philippines

Great Harvest Agri Chemicals Corporation to Sell MBI Products

Stocks Under $10 Weekly Summary

Last week, we closed a position for a large gain and used some of the proceeds to start a small stake in a fracking and desalination name.

Marrone Bio Innovations Announces The Launch Of Zelto™ For Control Of Foliar And Soil Dwelling Pests On Turf

Marrone Bio Innovations Announces The Launch Of Zelto™ For Control Of Foliar And Soil Dwelling Pests On Turf

Zelto™ Promotes Turf Health by Protecting Roots from the Ground Up Additional Turf Uses for Nematode Control are Allowed

Stocks Under $10 Weekly Summary

We added two new positions to the portfolio last week.

TheStreet Quant Rating: D- (Sell)